Tiwari Atul K, Mishra Anupa, Pandey Govind, Gupta Munesh K, Pandey Prem C
Department of Chemistry Indian Institute of Technology (BHU) Varanasi Uttar Pradesh 221005 India.
Department of Microbiology Dr. R.M.L. Awadh University Ayodhya Uttar Pradesh 224001 India.
Part Part Syst Charact. 2022 Jan;39(1):2100159. doi: 10.1002/ppsc.202100159. Epub 2021 Nov 21.
The COVID-19 infections have posed an unprecedented global health emergency, with nearly three million deaths to date, and have caused substantial economic loss globally. Hence, an urgent exploration of effective and safe diagnostic/therapeutic approaches for minimizing the threat of this highly pathogenic coronavirus infection is needed. As an alternative to conventional diagnosis and antiviral agents, nanomaterials have a great potential to cope with the current or even future health emergency situation with a wide range of applications. Fundamentally, nanomaterials are physically and chemically tunable and can be employed for the next generation nanomaterial-based detection of viral antigens and host antibodies in body fluids as antiviral agents, nanovaccine, suppressant of cytokine storm, nanocarrier for efficient delivery of antiviral drugs at infection site or inside the host cells, and can also be a significant tool for better understanding of the gut microbiome and SARS-CoV-2 interaction. The applicability of nanomaterial-based therapeutic options to cope with the current and possible future pandemic is discussed here.
新型冠状病毒肺炎感染已造成前所未有的全球卫生紧急状况,迄今已导致近300万人死亡,并在全球范围内造成了巨大的经济损失。因此,迫切需要探索有效且安全的诊断/治疗方法,以将这种高致病性冠状病毒感染的威胁降至最低。作为传统诊断方法和抗病毒药物的替代方案,纳米材料具有巨大潜力,可通过广泛应用应对当前乃至未来的卫生紧急状况。从根本上讲,纳米材料在物理和化学性质上具有可调节性,可用于下一代基于纳米材料的体液中病毒抗原和宿主抗体检测,作为抗病毒剂、纳米疫苗、细胞因子风暴抑制剂、在感染部位或宿主细胞内高效递送抗病毒药物的纳米载体,并且还可以成为更好地理解肠道微生物群与严重急性呼吸综合征冠状病毒2相互作用的重要工具。本文讨论了基于纳米材料的治疗方案在应对当前及未来可能大流行中的适用性。